tiprankstipranks
Astellas receives Complete Response Letter for Izervay, Apellis rallies
PremiumThe FlyAstellas receives Complete Response Letter for Izervay, Apellis rallies
3d ago
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Premium
The Fly
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
3d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
14d ago
Apellis price target lowered to $40 from $65 at Oppenheimer
PremiumThe FlyApellis price target lowered to $40 from $65 at Oppenheimer
16d ago
Apellis price target lowered to $51 from $63 at Citi
Premium
The Fly
Apellis price target lowered to $51 from $63 at Citi
16d ago
Apellis price target lowered to $30 from $43 at Wells Fargo
Premium
The Fly
Apellis price target lowered to $30 from $43 at Wells Fargo
16d ago
Apellis reports Q3 EPS (46c), consensus (30c)
PremiumThe FlyApellis reports Q3 EPS (46c), consensus (30c)
17d ago
Apellis expects cash to be sufficient to fund expenses to positive cash flow
Premium
The Fly
Apellis expects cash to be sufficient to fund expenses to positive cash flow
17d ago
Apellis Pharmaceuticals (APLS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Apellis Pharmaceuticals (APLS) Q3 Earnings Cheat Sheet
19d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100